Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ReCor Medical
MedTech
CMS to pay for renal denervation from Medtronic, Recor Medical
CMS delivered separate TPT payments to each developer, granting distinct codes to their procedures for reducing stubbornly high blood pressure.
Conor Hale
Nov 6, 2024 4:45am
Recor claims 1st FDA renal denervation approval for hypertension
Nov 8, 2023 10:07am
FDA panel backs ReCor, shuns Medtronic in renal denervation
Aug 24, 2023 11:28am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
ReCor Medical taps Siemens Healthineers alum as CEO
Jan 3, 2023 12:04pm
Medtronic, ReCor back renal denervation approach to hypertension
Sep 20, 2022 2:51pm
